Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Digital Phenotyping
100%
Population-based Cohort
18%
Risk Stratification
18%
Machine Learning Models
18%
Health Outcomes
9%
Stratification Strategy
9%
Disease Trajectory
9%
Longitudinal Data
9%
Liver Disease Progression
9%
Electronic Health Records
9%
Disease Onset
9%
Associated Diseases
9%
Disease Features
9%
Unsupervised Machine Learning
9%
Liver-related Outcomes
9%
Large-scale Implementation
9%
Comorbidity
9%
Routinely Collected Data
9%
Obesity
9%
Early Detection
9%
Integrated Health Care
9%
Liver Disease Prediction
9%
Early Risk
9%
Analytical Toolbox
9%
Liver Complications
9%
Latent Trait
9%
Artificial Intelligence Applications
9%
Care Relationship
9%
Healthcare Dataset
9%
Liver Cirrhosis
9%
Human Guidance
9%
Progressive Phenotype
9%
Long Follow-up
9%
Early Identification
9%
Machine Learning Approach
9%
Chronic Liver Disease
9%
Population Health
9%
Targeted Screening
9%
Individuals at Risk
9%
Liver-related Mortality
9%
Optimized Model
9%
Disease Groups
9%
Liver
9%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Diseases
36%
Risk Stratification
18%
Electronic Health Record
9%
Liver Cirrhosis
9%
Population Health
9%
Disease Course
9%
Chronic Liver Disease
9%
Comorbidity
9%
Artificial Intelligence
9%
Health Care
9%